These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36824453)

  • 41. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
    Li Z; Cui S; Geng L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):443-448. PubMed ID: 34053488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
    Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
    Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
    BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Myhre PL; Røsjø H; Sarvari SI; Ukkonen H; Rademakers F; Engvall JE; Hagve TA; Nagel E; Sicari R; Zamorano JL; Monaghan M; D'hooge J; Edvardsen T; Omland T
    Int J Cardiol; 2022 Aug; 361():14-17. PubMed ID: 35577165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
    Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
    Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Spironolactone on Hypoxia-Inducible Factor-1α in the Patients Receiving Coronary Artery Bypass Grafting.
    Lou YM; Zheng ZL; Xie LY; Lian JF; Shen WJ; Zhou JQ; Shao GF; Hu DX
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e101-e104. PubMed ID: 34173801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG.
    Holm J; Vidlund M; Vanky F; Friberg O; Håkanson E; Svedjeholm R
    Scand Cardiovasc J Suppl; 2013 Feb; 47(1):28-35. PubMed ID: 22989031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
    Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
    Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
    Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
    Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
    PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
    Ki YJ; Park S; Ha SI; Choi DH; Song H
    Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High N-Terminal proB-Type Natriuretic Peptide Indicates Elevated Risk of Death after Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction.
    Roth C; Schneider M; Dalos D; Gangl C; Toth C; Goliasch G; Berger R
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31234593
    [No Abstract]   [Full Text] [Related]  

  • 60. Elevated high-sensitivity troponin T levels at 1-year follow-up are associated with increased long-term mortality after TAVR.
    Seoudy H; Lambers M; Winkler V; Dudlik L; Freitag-Wolf S; Frank J; Kuhn C; Rangrez AY; Puehler T; Lutter G; Bramlage P; Frey N; Frank D
    Clin Res Cardiol; 2021 Mar; 110(3):421-428. PubMed ID: 33098469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.